Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Selen Kum Özşengezer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey. Hauptthemen laut MEDLINE: Nestin, Neuroblastoma, YAP-Signaling Proteins, Otx Transcription Factors. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dokuz Eylül University Scientific Research Projects Unit, Turkish Pediatric Oncology Group Association.
Abstract (Originalsprache)
Objectives
Neuroblastoma is the most common extracranial solid tumor in childhood. YAP (Yes‐associated protein) is a highly expressed protein in NB. Nestin is an important marker of neuronal differentiation in NB. Orthodenticle homeobox (OTX) is a transcription factor and is overexpressed in blastoma‐derived tumors. The aim of this study was to examine the potential roles of YAP‐1, Nestin, and OTX‐2 proteins in prognosis and risk stratification in neuroblastoma Methods Tumor sections of 56 patients with different NB risk groups were analyzed. YAP‐1, Nestin, and OTX‐2 protein expression levels were evaluated by immunohistochemical staining in NB patient tissue samples.
Results
YAP‐1, Nestin, and OTX‐2 protein expression levels were evaluated together with the clinical findings of NB patients. YAP‐1 was expressed in 18% of all tissues, while Nestin was expressed in 20.4%. OTX‐2 protein expression was found in 41.1% of the NB patients. YAP‐1 was expressed in 26.9% of high‐risk and 11.5% of low‐risk patients. Nestin was expressed in 24.4% high‐risk and 33.3% low‐risk patients. OTX‐2 was expressed in 68.2% high‐risk and 60% low‐risk patients.YAP‐1 was shown to provide survival advantages among risk groups.
Interpretation
The findings of this study support that YAP‐1 may be a potential prognostic biomarker for staging and risk‐group assignment of NB patients. YAP‐1 expression in neuroblastoma is associated with significantly poorer survival probabilities and should be considered as a potential therapeutic target. OTX‐2 is a promising predictive biomarker candidate, but its mechanisms need further investigation in neuroblastoma, as nestin expression is not significantly linked to patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey.
- Department of Clinical Oncology, Institute of Oncology, Dokuz Eylül University, Izmir, Turkey.
- Department of Pediatric Oncology, Institute of Oncology, Dokuz Eylül University, Izmir, Turkey.
- Department of Basic Medical Sciences, Department of Biostatistics and Medical Informatics, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.
ORCID-Profile: Selen Kum Özşengezer, Zekiye Sultan Altun, Gamze Sanlav, Burçin Baran, Deniz Kızmazoğlu, Safiye Aktaş, Pembe Keskinoğlu, Nur Olgun
Förderung
- Dokuz Eylül University Scientific Research Projects Unit
- Turkish Pediatric Oncology Group Association
Zitieren
APA
Kum Özşengezer, S., Altun, Z. S., Sanlav, G., Baran, B., Kızmazoğlu, D., Aktaş, S., Keskinoğlu, P., & Olgun, N. (2024). Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52136
Vancouver
Kum Özşengezer S, Altun ZS, Sanlav G, Baran B, Kızmazoğlu D, Aktaş S, et al. Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52136
BibTeX
@article{Kumzengezer2024,
author = {Kum Özşengezer, Selen and Altun, Zekiye Sultan and Sanlav, Gamze and Baran, Burçin and Kızmazoğlu, Deniz and Aktaş, Safiye and Keskinoğlu, Pembe and Olgun, Nur},
title = {Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52136}
}
EUVIMED